Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smart Genetics is a biotechnology company headquartered in Warsaw, Poland, dedicated to the field of personalized medicine through advanced genetic diagnostics. The company specializes in identifying genetic predispositions for neurodegenerative diseases, specifically focusing on Alzheimer's disease via its flagship "Smart Alzheimer's" test. This test analyzes the Apolipoprotein E (APOE) gene to provide individuals with a comprehensive risk profile and personalized health recommendations. By leveraging bioinformatics and molecular biology, Smart Genetics aims to make complex genomic information accessible and actionable for both patients and clinicians. Their mission centers on early detection and the implementation of preventative lifestyle strategies to improve long-term health outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smart Genetics.